BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 19617252)

  • 1. Suction, salvage, sutures, and potions: blood management post-aprotinin.
    Baker RA
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):122-6. PubMed ID: 19617252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned in antifibrinolytic therapy: The BART trial.
    Murkin JM
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 5. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 6. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 7. Can we really believe that aprotinin is safe in congenital heart surgery?
    Faraoni D
    Ann Thorac Surg; 2011 Mar; 91(3):987-8; author reply 988. PubMed ID: 21353050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
    Bizouarn P
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
    [No Abstract]   [Full Text] [Related]  

  • 9. The demise of aprotinin: our share of the blame.
    Sundt TM
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):729-31. PubMed ID: 18374748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
    Blanloeil Y
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):683-5. PubMed ID: 16919751
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment.
    Carrel T; Englberger L
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):875-6. PubMed ID: 19595607
    [No Abstract]   [Full Text] [Related]  

  • 12. III. Aprotinin and cardiac surgery: a sorry tale of evidence misused.
    McMullan V; Alston RP
    Br J Anaesth; 2013 May; 110(5):675-8. PubMed ID: 23599511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of aprotinin in cardiovascular surgery].
    Colorio C; Carreras LO
    Sangre (Barc); 1995 Jun; 40(3):207-11. PubMed ID: 7570273
    [No Abstract]   [Full Text] [Related]  

  • 14. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
    Hill SE
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
    [No Abstract]   [Full Text] [Related]  

  • 15. Aprotinin: 1 year on.
    Dietrich W
    Curr Opin Anaesthesiol; 2009 Feb; 22(1):121-7. PubMed ID: 19295302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
    McEvoy MD; Reeves ST; Reves JG; Spinale FG
    Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current methods to reduce the adverse haematological consequences of cardiopulmonary bypass.
    John LC; Deverall PB
    Br J Clin Pract; 1996 Jun; 50(4):203-6. PubMed ID: 8759566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is aprotinin safe when used in the context of profound hypothermia and circulatory arrest? A literary review.
    Hornick P; Taylor KM
    J Heart Valve Dis; 1995 Nov; 4(6):669-73. PubMed ID: 8611984
    [No Abstract]   [Full Text] [Related]  

  • 19. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ; Griesdale DE; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
    Swartz MF; Fink GW; Searles B
    J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.